Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-08

Clinical Trial Update: The Effect of Dexmedetomidine on Kidney Perfusion in Paediatric Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial examining the effect of dexmedetomidine on kidney perfusion in pediatric patients with congenital heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Mai Madkour | Conditions: Congenital Heart Disease | Phase 2 | Status: UNKNOWN